In Figure 1 of the initially published article, the direction of four arrows and the shape of three objects in the Markov simulation model, indicated in the attached file with red circles, were incorrectly shown. Figure 1 has been corrected to show the accurate model used in the study. These corrections have not changed the findings of the article.
. 2020 May 30;2(2):otaa036. doi: 10.1093/crocol/otaa036
Evaluation of the Optimal Position for Vedolizumab in the Japanese Treatment Paradigm for Ulcerative Colitis Using Markov Modeling
Akihito Uda
, Yuki Eto
, Yuxin Li
, Hiroyuki Matsuda
, Sven Demiya
, Tomoyuki Watanabe
, Mihoko Ota
, Ryuichi Iwakiri
, Ataru Igarashi
Akihito Uda, MPH
Find articles by Akihito Uda
Yuki Eto, MSc
Find articles by Yuki Eto
Yuxin Li, MSc
Find articles by Yuxin Li
Hiroyuki Matsuda, MSc
Find articles by Hiroyuki Matsuda
Sven Demiya, PhD, MBA
Find articles by Sven Demiya
Tomoyuki Watanabe, PhD
Find articles by Tomoyuki Watanabe
Mihoko Ota, MMA
Find articles by Mihoko Ota
Ryuichi Iwakiri, MD, PhD
Find articles by Ryuichi Iwakiri
Ataru Igarashi, PhD
Find articles by Ataru Igarashi
Collection date 2020 Apr.
© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC9802470 PMID: 36780243
This corrects the article "Evaluation of the Optimal Position for Vedolizumab in the Japanese Treatment Paradigm for Ulcerative Colitis Using Markov Modeling", otaa017.
